General Information of Drug Off-Target (DOT) (ID: OTA702JK)

DOT Name Discoidin, CUB and LCCL domain-containing protein 1 (DCBLD1)
Gene Name DCBLD1
Related Disease
Atrial fibrillation ( )
Colon cancer ( )
Colorectal adenocarcinoma ( )
Colorectal cancer ( )
Colorectal cancer, susceptibility to, 1 ( )
Colorectal cancer, susceptibility to, 10 ( )
Colorectal cancer, susceptibility to, 12 ( )
Colorectal carcinoma ( )
Colorectal neoplasm ( )
Lung adenocarcinoma ( )
Lung cancer ( )
Lung carcinoma ( )
Non-small-cell lung cancer ( )
Bipolar disorder ( )
Melanoma ( )
UniProt ID
DCBD1_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF00431 ; PF00754 ; PF03815
Sequence
MVPGARGGGALARAAGRGLLALLLAVSAPLRLQAEELGDGCGHLVTYQDSGTMTSKNYPG
TYPNHTVCEKTITVPKGKRLILRLGDLDIESQTCASDYLLFTSSSDQYGPYCGSMTVPKE
LLLNTSEVTVRFESGSHISGRGFLLTYASSDHPDLITCLERASHYLKTEYSKFCPAGCRD
VAGDISGNMVDGYRDTSLLCKAAIHAGIIADELGGQISVLQRKGISRYEGILANGVLSRD
GSLSDKRFLFTSNGCSRSLSFEPDGQIRASSSWQSVNESGDQVHWSPGQARLQDQGPSWA
SGDSSNNHKPREWLEIDLGEKKKITGIRTTGSTQSNFNFYVKSFVMNFKNNNSKWKTYKG
IVNNEEKVFQGNSNFRDPVQNNFIPPIVARYVRVVPQTWHQRIALKVELIGCQITQGNDS
LVWRKTSQSTSVSTKKEDETITRPIPSEETSTGINITTVAIPLVLLVVLVFAGMGIFAAF
RKKKKKGSPYGSAEAQKTDCWKQIKYPFARHQSAEFTISYDNEKEMTQKLDLITSDMADY
QQPLMIGTGTVTRKGSTFRPMDTDAEEAGVSTDAGGHYDCPQRAGRHEYALPLAPPEPEY
ATPIVERHVLRAHTFSAQSGYRVPGPQPGHKHSLSSGGFSPVAGVGAQDGDYQRPHSAQP
ADRGYDRPKAVSALATESGHPDSQKPPTHPGTSDSYSAPRDCLTPLNQTAMTALL

Molecular Interaction Atlas (MIA) of This DOT

15 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Atrial fibrillation DIS15W6U Strong Genetic Variation [1]
Colon cancer DISVC52G Strong Genetic Variation [2]
Colorectal adenocarcinoma DISPQOUB Strong Genetic Variation [2]
Colorectal cancer DISNH7P9 Strong Genetic Variation [2]
Colorectal cancer, susceptibility to, 1 DISZ794C Strong Genetic Variation [2]
Colorectal cancer, susceptibility to, 10 DISQXMYM Strong Genetic Variation [2]
Colorectal cancer, susceptibility to, 12 DIS4FXJX Strong Genetic Variation [2]
Colorectal carcinoma DIS5PYL0 Strong Genetic Variation [2]
Colorectal neoplasm DISR1UCN Strong Genetic Variation [2]
Lung adenocarcinoma DISD51WR Strong Genetic Variation [3]
Lung cancer DISCM4YA Strong Genetic Variation [4]
Lung carcinoma DISTR26C Strong Genetic Variation [4]
Non-small-cell lung cancer DIS5Y6R9 Strong Genetic Variation [3]
Bipolar disorder DISAM7J2 Limited Genetic Variation [5]
Melanoma DIS1RRCY Limited Biomarker [6]
------------------------------------------------------------------------------------
⏷ Show the Full List of 15 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
8 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of Discoidin, CUB and LCCL domain-containing protein 1 (DCBLD1). [7]
Tretinoin DM49DUI Approved Tretinoin increases the expression of Discoidin, CUB and LCCL domain-containing protein 1 (DCBLD1). [8]
Acetaminophen DMUIE76 Approved Acetaminophen increases the expression of Discoidin, CUB and LCCL domain-containing protein 1 (DCBLD1). [9]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate increases the expression of Discoidin, CUB and LCCL domain-containing protein 1 (DCBLD1). [10]
Testosterone DM7HUNW Approved Testosterone increases the expression of Discoidin, CUB and LCCL domain-containing protein 1 (DCBLD1). [11]
Urethane DM7NSI0 Phase 4 Urethane increases the expression of Discoidin, CUB and LCCL domain-containing protein 1 (DCBLD1). [12]
Trichostatin A DM9C8NX Investigative Trichostatin A increases the expression of Discoidin, CUB and LCCL domain-containing protein 1 (DCBLD1). [16]
Milchsaure DM462BT Investigative Milchsaure decreases the expression of Discoidin, CUB and LCCL domain-containing protein 1 (DCBLD1). [17]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Drug(s)
3 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Discoidin, CUB and LCCL domain-containing protein 1 (DCBLD1). [13]
PMID28870136-Compound-52 DMFDERP Patented PMID28870136-Compound-52 affects the phosphorylation of Discoidin, CUB and LCCL domain-containing protein 1 (DCBLD1). [14]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the methylation of Discoidin, CUB and LCCL domain-containing protein 1 (DCBLD1). [15]
------------------------------------------------------------------------------------

References

1 Multi-ethnic genome-wide association study for atrial fibrillation.Nat Genet. 2018 Jun 11;50(9):1225-1233. doi: 10.1038/s41588-018-0133-9.
2 Genome-wide association study of colorectal cancer identifies six new susceptibility loci.Nat Commun. 2015 Jul 7;6:7138. doi: 10.1038/ncomms8138.
3 Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations.Lancet Respir Med. 2019 Oct;7(10):881-891. doi: 10.1016/S2213-2600(19)30144-4. Epub 2019 Jul 17.
4 Polymorphism of rs9387478 correlates with overall survival in female nonsmoking patients with lung cancer.Int J Biol Markers. 2016 May 28;31(2):e144-52. doi: 10.5301/jbm.5000180.
5 Genome-wide association study identifies 30 loci associated with bipolar disorder.Nat Genet. 2019 May;51(5):793-803. doi: 10.1038/s41588-019-0397-8. Epub 2019 May 1.
6 Aggressiveness of human melanoma xenograft models is promoted by aneuploidy-driven gene expression deregulation.Oncotarget. 2012 Apr;3(4):399-413. doi: 10.18632/oncotarget.473.
7 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
8 Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure. Toxicol Sci. 2011 Dec;124(2):370-7.
9 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
10 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
11 The exosome-like vesicles derived from androgen exposed-prostate stromal cells promote epithelial cells proliferation and epithelial-mesenchymal transition. Toxicol Appl Pharmacol. 2021 Jan 15;411:115384. doi: 10.1016/j.taap.2020.115384. Epub 2020 Dec 25.
12 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
13 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
14 Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. Toxicol Appl Pharmacol. 2022 Aug 15;449:116110. doi: 10.1016/j.taap.2022.116110. Epub 2022 Jun 7.
15 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019 Oct 10;11(1):138. doi: 10.1186/s13148-019-0725-y.
16 From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. Arch Toxicol. 2014 Jul;88(7):1451-68.
17 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.